SCHEMBL11050657

SCHEMBL11050657

CCCCn1ccnc1O[Cl+3]([O-])([O-])[O-]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.57
POLB P06746 1/20 0.57
KMT2A Q03164 1/20 0.57
TLR8 Q9NR97 2/20 0.46
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 4/20 0.35
HTT P42858 2/20 0.35
TSHR P16473 1/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
AGTR1 P30556 1/20 0.33
AGTR2 P50052 1/20 0.33
CYP19A1 P11511 4/20 0.33
CYP2D6 P10635 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL893369 0.80 ALDH1A1 (0.59) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL10352847 0.76 TLR8 (0.61) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL1829325 0.74 ALDH1A1 (0.53) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL2960713 0.74 ALDH1A1 (0.53) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL28837797 0.73 TLR8 (0.57) ALDH1A1POLBKMT2ATLR8LMNA
SCHEMBL4918147 0.73 CHRNB2 (0.41) KMT2AHTTKDM4E
SCHEMBL329177 0.73 ALDH1A1 (1.00) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL28276561 0.73 ALDH1A1 (1.00) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL3171422 0.73 ALDH1A1 (0.51) ALDH1A1POLBKMT2ATLR8CYP1A2
SCHEMBL6115119 0.72 ALDH1A1 (0.69) ALDH1A1POLBKMT2ATLR8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000951-B1 PHARMACEUTICAL FORMULATIONS COMPRISING 1-SUBSTITUTED IMIDAZOLES, 1-SUBSTITUTED IMIDAZOLES AND 1-SUBSTITUTED IMIDAZOLES FOR USE IN THE TREATMENT OR PROPHYLAXIS OF THROMBO-EMBOLIC DISORDERS THE WELLCOME FOUNDATION LIMITED (GB) 1984-05-23 EP disclosed
US-4284641-A ANTITHROMBOEMBOLIC AGENT BURROUGHS WELLCOME CO. (US) 1981-08-18 US disclosed
EP-0000951-A1 Pharmaceutical Formulations comprising 1-substituted imidazoles, 1-substituted imidazoles and 1-substituted imidazoles for use in the treatment or prophylaxis of thrombo-embolic disorders THE WELLCOME FOUNDATION LIMITED (GB) 1979-03-07 EP disclosed